GBS and Iomustine

<p><span data-sheets-value= "{"1":2,"2":"Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage. "}" data-sheets-userformat= "{"2":15359,"3":{"1":0},"4":{"1":3,"3":2},"5":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"6":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"7":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"8":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"9":0,"10":1,"11":4,"12":0,"14":{"1":2,"2":0},"15":"Calibri","16":11}"> Dr. Howard Colman discusses the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.</span></p> <p>Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/09160/A_Glioblastoma_Drug_Is_Abruptly_Withdrawn_from.6.aspx</p> <p> </p>